A Compound Heterozygous Protein C Deficiency with a Single Nucleotide G Deletion Encoding Gly-381 and an Amino Acid Substitution of Lys for Gla-26

Summary

We report genetic abnormalities of protein C gene in a male infant who developed neonatal purpura fulminans. DNA-sequence analysis of all exons in protein C gene in this family revealed two mutations. The first abnormality, derived from the mother, was a deletion of one of four consecutive G at nucleotide number 10758 in exon IX which would result in a frame shift mutation and completely change amino acid sequence from Gly381 in the carboxyl-terminal region of protein C. The second abnormality, derived from the father, was a single nucleotide mutation from G to A in the codon (GAG to AAG) at nucleotide number 2977 in exon III, which would result in a substitution of Lys for γ-carboxyglutamic acid (Gla)26. This change would be responsible for the reduced immunological protein C levels of the patient and the father, estimated by a monoclonal antibody which recognizes the Gla-domain in a Ca²⁺-dependent manner (3.8% and 57%, respectively). Partially purified abnormal protein C from the father’s plasma showed a normal amidolytic activity and a change in the electrophoretic mobility. We detected the above mutations in his family members using two methods; one was a creation of new restriction enzyme sites using mutagenic primers and the other was single nucleotide primer extension. Both methods are rapid and useful for the diagnosis of prenatal protein C abnormalities.

• References

• 1 Stenflo J. A new vitamin K-dependent protein: Purification from bovine plasma and preliminary characterization. J Biol Chem 1976; 251: 355-363
• 2 Kisiel W. Human plasma protein C. Isolation, characterization and mechanism of activation by α-thrombin. J Clin Invest 1979; 64: 761-769
• 3 Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982; 257: 859-864
• 4 Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-1352
• 5 Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4747
• 6 de Fouw NJ, Haverkate F, Bertina RM, Koopmann J, van Wijngaardan A, van Hinsberg VWM. The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro. Blood 1986; 67: 1189-1193
• 7 Suzuki K, Stenflo J, Dahlback B, Teodorsson B. Inactivation of human coagulation factor V by activated protein C. J Biol Chem 1983; 258: 1189-1193
• 8 van Hinsberg VWM, Bertina RM, van Wijngaarden A, van Tilburg NH, Emeis JJ, Haverkate F. Activated protein C decreases plasminogen activator inhibitor activity in endothelial cell conditioned media. Blood 1985; 65: 444-451
• 9 Plutzky J, Hosking JA, Long GL, Crabtree GR. Evolution and organization of the human protein C gene. Proc Natl Acad Sci USA 1986; 83: 546-550
• 10 Broekmans AW, Conard F. Hereditary protein C deficiency. In: Protein C and Related Proteins. Bertina RM. (eds) Churchill Living-stone; Edinburgh: 1988: 160
• 11 Marler RA, Mastovich S. Hereditary protein C deficiency: a review of the genetics, clinical presentation, dignosis and treatment. Blood Coagul Fibrinol 1990; 1: 319-330
• 12 Branson HE, Katz J, Marble R, Griffin JH. Inherited protein C deficiency and coumarin responsive chronic relapsing purpura fulminans in a newbom infant. Lancet 1983; 2: 1165-1168
• 13 Suzuki K, Hayashi T, Koyama M, Yoshimura T, Shimamoto M, Kimura N, Kita M. Rapid homogenous enzyme immunoassay of plasma protein C. Clin Chim Acta 1989; 184: 227-234
• 14 Wakabayashi K, Sakata Y, Aoki N. Conformation-specific monoclonal antibodies to the calcium-induced structure of protein. C. J Biol Chem 1986; 261: 11097-11105
• 15 Martinoli JL, Stocker K. Fast functional protein C assay using Protac C®, a novel protein C activator. Thromb Res 1986; 43: 253-264
• 16 Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with thermostable DNA polymerase. Science 1988; 239: 487-491
• 17 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467
• 18 Kuppuswamy MN, Hoffmann JW, Kasper CK, Spitzer SG, Groce SL, Bajaj SP. Single nucleotide. primer extension to detect genetic diseases: Experimental application to hemophilia B (factor IX) and cystic fibrosis genes. Proc Natl Acad Sci USA 1991; 88: 1143-1147
• 19 Burnett WN. “Western blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981; 112: 195-203
• 20 LeGendre N, Matsudaira P. In: A Practical Guide to Protein and Peptide Purification for Microsequencing. Matsudaira P. (ed) Academic Press, Inc.; San Diego, CA: 1989: 49-57
• 21 Yamamoto K, Tanimoto M, Emi N, Matsushita T, Takamatsu J, Saito H. Impaired secretion of elongated mutant of protein C (Protein C-Nagoya). J Clin Invest 1992; 90: 2439-2446
• 22 Tokunaga F, Wakabayashi S, Sato H, Arakawa M, Tawaraya H, Koide T. Identification of one base deletion in exon IX of protein C gene that cause a type I deficiency. Thromb Res 1992; 68: 417-423
• 23 Zhang L, Jhingan A, Castellino J. Role of individual γ-carboxy-glutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. Blood 1992; 80: 942-952
• 24 Bovill EG, Tomczak JA, Grant B, Bhushan F, Pillemer E, Rainville IR, Long GL. Protein C_Vermont2: Symptomatic type II protein C deficiency associated with two Gla domain mutations. Blood 1992; 79: 1456-1465
• 25 Mimuro J, Matsumura S, Kaneko M, Yoshitake S, Iijima K, Nakamura K, Sakata Y, Matsuda M. An abnormal protein C (protein C Yonago) with an amino acid substitution of Gly for Arg-15 caused by a single base mutation of C to G in codon 57 (CGG → GGG): Deteriorated calcium-dependent conformation of the γ-carboxy-glutamic acid domain relative to a thrombotic tendency. Int J Haematol 1993; 57: 9-14